A Meta-Analysis of the Alcohol Treatment Outcome Literature: 1993 to 2000

Total Page:16

File Type:pdf, Size:1020Kb

A Meta-Analysis of the Alcohol Treatment Outcome Literature: 1993 to 2000 Utah State University DigitalCommons@USU All Graduate Theses and Dissertations Graduate Studies 5-2002 A Meta-analysis of the Alcohol Treatment Outcome Literature: 1993 to 2000 Anthony Phillip Tranchita Utah State University Follow this and additional works at: https://digitalcommons.usu.edu/etd Part of the Psychology Commons Recommended Citation Tranchita, Anthony Phillip, "A Meta-analysis of the Alcohol Treatment Outcome Literature: 1993 to 2000" (2002). All Graduate Theses and Dissertations. 6366. https://digitalcommons.usu.edu/etd/6366 This Thesis is brought to you for free and open access by the Graduate Studies at DigitalCommons@USU. It has been accepted for inclusion in All Graduate Theses and Dissertations by an authorized administrator of DigitalCommons@USU. For more information, please contact [email protected]. A META-ANALYSIS OF OF THE THE ALCOHOL ALCOHOL TREATMENT TREATMENT OUTCOME LITERATURE: 1993 TO 2000 by Anthony PhillipPhillip Tranchita A thesis submitted in partial fulfillment of the requirementsrequirements for for the degree oof f MASTER OF SCIENCE in Psychology Approved : ~,1v,,$ ca;; - ~~~ Oavid M: Stein. Ph.D~ - Carolyn if.Barcus. Ed.D. Major Professor Committee Member L1._&wf~ /2]~)µ- SusanL. Crowley, Ph.D. / ThqdlasL. Kent. Ph .D. ' Committee Member Dean of Graduate Studies UTUTAH AH STATE UNIVERSITYUNIVERSITY Logan.Logan, Utah 2002 INFORMATION TO USERS This manuscript has been reproduced from the microfilm master. UMI films the text directly from the original or copy submitted. Thus, some thesis and dissertation copies are in typewriter face, while others may be from any type of computer printer. The quality of this reproduction is dependent upon the quality of the copy submitted. Broken or indistinct print, colored or poor quality illustrations and photographs, print bleedthrough, substandard margins, and improper alignment can adversely affect reproduction. In the unlikely event that the author did not send UMI a complete manuscript and there are missing pages, these will be noted. Also, if unauthorized copyright material had to be removed, a note will indicate the deletion. Oversize materials (e.g., maps, drawings, charts) are reproduced by sectioning the original, beginning at the upper left-hand comer and continuing from left to right in equal sections with small overlaps. ProQuest Information and Learning 300 North Zeeb Road, Ann Arbor, Ml 48106-1346 USA 800-521-0600 UMI® UMI Number: 1410494 UMI® UMI Microform 1410494 Copyright 2002 by ProQuest Information and Learning Company. All rights reserved. This microform edition is protected against unauthorized copying under Title 17, United States Code. ProQuest Information and Learning Company 300 North Zeeb Road P.O.Box 1346 Ann Arbor, Ml 46106-1346 ABSTRACT A Meta-analysis o f the Alcohol Treatment Outcome Literature: 1993 to 2000 by Anthony Phillip Tranchita, Master o f Science Utah State University, 2002 Major Professor: Dr. David Stein Department: Psychology Alcohol misuse is a very common problem with high financial and personal costs. Treatment requires allocation o f limited resources for optimal impact. Responsible decision making in this area should be based upon reasoned weighing o f research evidence. Miller and colleagues completed a meta-analytic review of all controlled studies published before 1992 to help clinicians do just that. The coding system they employed examined methodological quality, as well as outcome, to obtain a rank­ ordering o f treatments that seem to have the most quality research support. The current study attempts to extend this work utilizing the same coding on studies published since 1992, and combine both databases of articles. Revised rank orderings o f treatments and conclusions regarding variables related to outcomes are reported. Implications are discussed, along with limitations of this review. An upward trend in methodological quality over time was also discovered. (144 pages) ACKNOWLEDGMENTS I would like to thank David Stein for his guidance and patience working with me on this project. Further, I would like to thank Susan Crowley and Carolyn Barcus for their participation on my committee, their helpful suggestions, and their occasional questions/reminders regarding my progress toward completion. I would also like to thank Karen Ranson for her hard work in helping to format and prepare this document. Lastly, I want to thank my wife for tolerating me on those nights when it felt as though I would never finish. I could not have done it without you. Anthony Phillip Tranchita CONTENTS Page ABSTRACT ............................................................................................................................ ii ACKNOWLEDGMENTS .................................................................................................. iii LIST OF TABLES ............................................................................................................... vi LIST OF FIGURE .................................................................................................................. viii INTRODUCTION ............................................................................................................... I REVIEW OF LITERATURE ............................................................................................ 4 Reviews of Pharmacological Treatments ............................................................. 4 Reviews o f Single Nonpharmacological Treatments ......................................... 7 Reviews of Meta-Analyses Comparing Different Treatment Modalities 15 RATIONALE FOR CURRENT STUDY ....................................................................... 22 Procedures for Current Study .................................................................................. 22 Analysis ......................................................................................................................... 25 RESULTS ............................................................................................................................... 32 Reliability o f New Codings ....................................................................................... 32 Notes on Combining Databases .............................................................................. 33 Psychometric Properties o f Coded Variables ...................................................... 35 Summary o f Cumulative Evidence Scores ........................................................... 36 Summary of Ratings by Article for Each Modality ............................................. 40 Treatment Modalities Included in This Review .................................................. 40 Trend o f Methodological Quality ........................................................................... 62 Variables Predictive o f Outcome ............................................................................ 67 DISCUSSION ........................................................................................................................ 70 Efficacy of Psychosocial and Behavioral Treatment Modalities ..................... 70 Efficacy o f Pharmacological Treatments ............................................................... 74 Trends in Methodological Quality .......................................................................... 77 Variables Predictive o f Outcome ............................................................................ 77 Clinical Implications .................................................................................................... 78 Implications for Research .......................................................................................... 80 V Page Limitations and Future Directions ................................................................................ 81 The “Take Home” Message ..................................................................................... 83 REFERENCES ...................................................................................................................... 85 APPENDIXES ....................................................................................................................... 115 Appendix A: Coding Manual from Miller et al........................................................... 116 Appendix B: All New Codings, Including All Disagreements for Inter-Rater Reliability ......................................................................... 129 LIST OF TABLES Table Page 1 Top Five Ranked Treatment Modalities in Three Meta-Analyses ............... 17 2 Comparison of Initial Ratings by Present Author to Those of Miller et al. (1995) ....................... 7 ..................................................................................... 24 3 Computation of MQS and Product Score for Change, Wilkins-Haug, Berman, and Goetz (1999) .................................................................................... 29 4 Summary o f Inter-Rater Reliability o f Codings ................................................ 33 5 Values Listed of Methodological Quality Scores in Modality Tables and Appendix o f Miller et al. (1995) .................................................................. 34 6 Psychometric Characteristics of Coded Variables for Entire Database ...... 36 7 Summary of Cumulative Evidence Scores and Methodological Quality for All Modalities ..................................................................................... 38 8 Summary of Treatment Modalities ...................................................................
Recommended publications
  • The Effect of Aversion Therapy on Students’ Attitude Towards Cigarette Smoking in Anambra State Prof
    GSJ: Volume 7, Issue 9, September 2019 ISSN 2320-9186 1336 GSJ: Volume 7, Issue 9, September 2019, Online: ISSN 2320-9186 www.globalscientificjournal.com THE EFFECT OF AVERSION THERAPY ON STUDENTS’ ATTITUDE TOWARDS CIGARETTE SMOKING IN ANAMBRA STATE PROF. NWANKWO, C. A PROFESSOR OF COUNSELLING PSYCHOLOGY NNAMIDI AZIKIWE UNIVERSITY AWKA- ANAMBRA STATE AND NWOSU IKECHUKWU AUGUSTINE DEPARTMENT OF GUIDANCE AND COUNSELLING FACULTY OF EDUCATION NNAMIDI AZIKIWE UNIVERSITY AWKA- ANAMBRA STATE AND AKPOJIVI, OVIE BRIGHT NIGERIAN POSTAL SERVICE [email protected] Cigarette smoking is fast becoming an addictive behaviour among senior secondary school students which is responsible for their unprecedented rise into maturity on the wrong path. This study investigated the effect of aversion therapy on students’ attitude towards cigarette smoking in Anambra state. one research questions guided the study and one null hypotheses were tested at 0.05 level of significance. The design for the study was pure experimental. The study has a population of 1800 SS 2 students in secondary school in Awka South Local Government Area of Anambra State. A sample of 62 SS2 students with positive attitude towards cigarette smoking was selected through purposive sampling technique. Instrument for data collection was the Cigarette Smoking Questionnaire (CSQ) developed by the researcher. Data collected were analyzed using mean and analysis of co-variance (ANCOVA). Findings of the study indicated that aversion therapy is ineffective in modifying cigarette smoking attitude. Based on the findings, it was recommended among others that aversion should not be adopted by counsellors as treatment for modifying cigarette smoking attitude of secondary school students in Anambra state.
    [Show full text]
  • Aversion Therapy Rodger K
    Digital Commons @ George Fox University Faculty Publications - Grad School of Clinical Graduate School of Clinical Psychology Psychology 1999 Aversion Therapy Rodger K. Bufford George Fox University, [email protected] Follow this and additional works at: https://digitalcommons.georgefox.edu/gscp_fac Part of the Counseling Commons, and the Psychology Commons Recommended Citation Bufford, Rodger K., "Aversion Therapy" (1999). Faculty Publications - Grad School of Clinical Psychology. 290. https://digitalcommons.georgefox.edu/gscp_fac/290 This Article is brought to you for free and open access by the Graduate School of Clinical Psychology at Digital Commons @ George Fox University. It has been accepted for inclusion in Faculty Publications - Grad School of Clinical Psychology by an authorized administrator of Digital Commons @ George Fox University. For more information, please contact [email protected]. Aversion Therapy ferred to as the "hot seat." The basic difference is ance. Often escape training is used initially, then in application. Psychodramatists encourage the pro­ modified into avoidance training. tagonist to confront persons, things, and self. The In escape training the target stimulus is pre­ Gestalt therapist uses the hot seat to help the client sented; then an unpleasant stimulus such as electric encounter parts and dimensions of the self. shock occurs. After brief exposure to the two stimuli, the individual escapes from the stimuli by making J. H. VANDER MAY a specified response. For example, a transvestite is given an article of women's clothing to put on and See GESTALT TECHNIQUES; GESTALT THERAPY. then administered electric shock. Once the clothing is removed, shock is terminated. Aversion Therapy. Aversion therapy uses anumber In avoidance training the individual is presented of techniques and stimuli to weaken or eliminate with the stimulus that elicits the problem behavior.
    [Show full text]
  • 986 Anxiolytic Sedatives Hypnotics and Antipsychotics
    986 Anxiolytic Sedatives Hypnotics and Antipsychotics Cyclobarbital (BAN, rINN) Detomidine Hydrochloride (BANM, USAN, rINNM) for the sedation of mechanically ventilated patients in intensive care. Dexmedetomidine is given as the hydrochloride, but doses Ciclobarbital; Cyclobarbitalum; Cyclobarbitone; Cyklobarbital; Demotidini Hydrochloridum; Detomidiinihydrokloridi; Detomi- are expressed in terms of the base. Dexmedetomidine hydrochlo- din hydrochlorid; Détomidine, chlorhydrate de; Detomidin-hid- Ethylhexabital; Hexemalum; Syklobarbitaali. 5-(Cyclohex-1-enyl)- ride 118 micrograms is equivalent to about 100 micrograms of 5-ethylbarbituric acid. roklorid; Detomidinhydroklorid; Detomidini hydrochloridum; dexmedetomidine. Hidrocloruro de detomidina; MPV-253-AII. 4-(2,3-Dimethylben- Циклобарбитал It is given in sodium chloride 0.9% by intravenous infusion in a zyl)imidazole hydrochloride. C12H16N2O3 = 236.3. loading dose equivalent to 1 microgram/kg of dexmedetomidine CAS — 52-31-3. Детомидина Гидрохлорид over 10 minutes, followed by a maintenance infusion of 0.2 to ATC — N05C A10. C12H14N2,HCl = 222.7. 0.7 micrograms/kg per hour for up to 24 hours. Reduced doses ATC Vet — QN05C A10. CAS — 76631-46-4 (detomidine); 90038-01-0 (detomi- may be necessary in patients with hepatic or renal impairment, or dine hydrochloride). in the elderly. The racemate, medetomidine (p.1006), is used as the hydrochlo- H ride in veterinary medicine. O N O CH3 ◊ References. N CH3 H3C 1. Venn RM, et al. Preliminary UK experience of dexmedetomi- NH dine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia 1999; 54: 1136–42. HN 2. Bhana N, et al. Dexmedetomidine. Drugs 2000; 59: 263–8. O 3. Coursin DB, et al. Dexmedetomidine. Curr Opin Crit Care (detomidine) 2001; 7: 221–6.
    [Show full text]
  • Behandling Av Ångestsyndrom
    Behandling av ångestsyndrom En systematisk litteraturöversikt Volym 2 September 2005 SBU • Statens beredning för medicinsk utvärdering The Swedish Council on Technology Assessment in Health Care SBU utvärderar sjukvårdens metoder SBU (Statens beredning för medicinsk utvärdering) är en statlig myn- Behandling av ångestsyndrom dighet som utvärderar sjukvårdens metoder. SBU analyserar nytta och kostnader för olika medicinska metoder och jämför vetenskapens stånd- punkt med svensk vårdpraxis. Målet är ett bättre beslutsunderlag för En systematisk litteraturöversikt alla som avgör vilken sjukvård som ska bedrivas. Välkommen att besöka SBU:s hemsida, www.sbu.se Volym 2 SBU ger ut tre serier av rapporter. I den första serien presenteras utvär- deringar som utförts av SBU:s projektgrupper. Dessa utvärderingar Projektgrupp åtföljs alltid av en sammanfattning och slutsatser fastställda av SBU:s Lars von Knorring Ingrid Håkanson styrelse och råd. Denna rapportserie ges ut med gula omslag. I den andra (ordförande) (projektassistent) serien, med vita omslag, presenteras aktuella kunskaper inom något Viveka Alton Lundberg Agneta Pettersson område av sjukvården där behov av utvärdering kan föreligga. Den tredje Vanna Beckman (projektledare under serien, Alert-rapporterna, avser tidiga bedömningar av nya metoder inom (deltog 1995–2002) perioden 2004–2005) hälso- och sjukvården. Susanne Bejerot Per-Anders Rydelius Roland Berg Sten Thelander (deltog 1995–2002) (projektledare under Cecilia Björkelund perioden 1995–2004) Per Carlsson Helene Törnqvist (deltog 1995–1999) (deltog 1999–2005) Elias Eriksson Kristian Wahlbeck (deltog 1995–2001) (deltog 2002–2005) Tom Fahlén Hans Ågren Mats Fredrikson Rapporten ”Behandling av ångestsyndrom” består av två volymer (nr 171/1+2) och kan beställas från: Externa granskare SBU, Box 5650, 114 86 Stockholm Fredrik Almqvist Per Høglend Besöksadress: Tyrgatan 7 Alv A.
    [Show full text]
  • Search Terms for Pubmed
    Search terms for Pubmed ("Schizophrenia"[Mesh] OR "Paranoid Disorders"[Mesh] OR schizo*[Title/Abstract] OR psychotic*[Title/Abstract] OR psychosis[Title/Abstract] OR psychoses[Title/Abstract]) AND ("Psychotherapy"[Mesh] or "Behavior Therapy"[Mesh] or "Cognitive Therapy"[Mesh] or "Complementary Therapies"[Mesh] or "Psychoanalysis"[Mesh] or "Counseling"[Mesh] or "Hypnosis"[Mesh] or "Association"[Mesh] or "Association Learning"[Mesh] OR abreaction[Title/Abstract] OR "acceptance[Title/Abstract] AND commitment therapy"[Title/Abstract] OR "acting out"[Title/Abstract] OR adlerian[Title/Abstract] OR "analytical psychotherapy"[Title/Abstract] OR "analytical psychotherapies"[Title/Abstract] OR "anger control"[Title/Abstract] OR "anger management"[Title/Abstract] OR "animal therapy"[Title/Abstract] OR "animal therapies"[Title/Abstract] OR "art therapy"[Title/Abstract] OR "art therapies"[Title/Abstract] OR "assertive training"[Title/Abstract] OR "assertiveness training"[Title/Abstract] OR "attention training technique"[Title/Abstract] OR "autogenic training"[Title/Abstract] OR autosuggestion[Title/Abstract] OR "aversion therapy"[Title/Abstract] OR "aversion therapies"[Title/Abstract] OR "balint group"[Title/Abstract] OR befriending[Title/Abstract] OR "behavior contracting"[Title/Abstract] OR "behavior modification"[Title/Abstract] OR "behavior regulation"[Title/Abstract] OR "behavior therapy"[Title/Abstract] OR "behavior therapies"[Title/Abstract] OR "behaviour contracting"[Title/Abstract] OR "behaviour modification"[Title/Abstract] OR "behaviour
    [Show full text]
  • Cognitive-Behavioral Therapy Boundless
    Cognitive-Behavioral Therapy Boundless Cognitive Therapy Cognitive therapy seeks to help a client overcome difficulties by identifying and changing dysfunctional thought patterns. 1. fig. 1 shows a group cognitive therapy session Clinicians use therapy sessions to help clients address and change their negative cognitive biases. Cognitive therapy (CT) is one of the therapeutic approaches within the larger group of cognitive behavioral therapies (CBT) and was first expounded by Aaron T. Beck in the 1960s. Cognitive-based therapies have gained increasing use in the past several decades, beginning with the cognitive revolution in 1956. CT is a psychotherapy quite distinct from other mainstream forms such as psychoanalytic or behavioral psychotherapy: rather than focusing on motivations or instincts, it is based on an information-processing model of human behavior and psychopathology. Cognitive distortions, or exaggerated and irrational thoughts, were believed to perpetuate psychological disorders. The process of learning to refute these distortions is called cognitive restructuring. Cognitive therapy may consist of testing a client's assumptions and identifying how client's unquestioned thoughts are distorted, unrealistic and unhelpful. Once these thoughts have been challenged, the client's feelings about the subject matter of those thoughts can be more readily changed. Cognition: Any element of knowledge including attitude, emotion, belief, or behavior. Schema: A person's worldview; an outline or image universally applicable to a general conception, under which it is likely to be presented to the mind Source URL: https://www.boundless.com/psychology/psychological-therapies/cognitive-behavioral-therapy/ Saylor URL: http://www.saylor.org/courses/psych404/ Attributed to: [Boundless] www.saylor.org Page 1 of 20 Cognitive Distortion: Exaggerated and irrational thoughts, believed to perpetuate psychological disorders.
    [Show full text]
  • Acamprosate Pharmaceutical Form(S)/Strength: Gastro-Resistant Tablet P-RMS: IE/H/PSUR/0011/002 Date of FAR: 09.02.2012 4.3 Contraindications
    Core Safety Profile Active substance: Acamprosate Pharmaceutical form(s)/strength: Gastro-resistant tablet P-RMS: IE/H/PSUR/0011/002 Date of FAR: 09.02.2012 4.3 Contraindications {Tradename} is contraindicated in patients with hypersensitivity to acamprosate or to any of the excipients. Acamprosate is contraindicated in patients with renal impairment (serum creatinine >120 micromol/l), breastfeeding women (see section 4.6) 4.4 Special warnings and precautions for use The safety and efficacy of {Tradename} has not been established in patients younger than 18 years or older than 65 years. {Tradename} is therefore not recommended for use in these populations. The safety and efficacy of {Tradename} has not been established in patients with severe liver insufficiency (Childs-Pugh Classification C). Because the interrelationship between alcohol dependence, depression and suicidality is well recognised and complex, it is recommended that alcohol-dependent patients, including those treated with acamprosate, be monitored for respective symptoms. Abuse and dependence Non-clinical studies suggest that acamprosate has little or no abuse potential. No evidence of dependence on acamprosate was found in any clinical study thus demonstrating that acamprosate has no significant dependence potential. 4.5 Interaction with other medicinal products and other forms of interaction No change in the frequency of clinical and/or biological adverse reactions has been shown when acamprosate is used concomitantly with disulfiram, oxazepam, tetrabamate or meprobamate. In clinical trials, acamprosate has been safely administered in combination with antidepressants, anxiolytics, hypnotics and sedatives, and non-opioid analgesics. The concomitant intake of alcohol and {Tradename} does not affect the pharmacokinetics of either alcohol or acamprosate.
    [Show full text]
  • Who Seeks Treatment? Psychotherapy Psychoanalysis
    12/6/11 Who Seeks Treatment? Psychotherapy 15% of U.S population in a given year We will limit ourselves to 4 types: Most common presenting problems • Psychodynamic-Unconscious conflicts and motivations • Anxiety and Depression • Humanistic-Importance of self-esteem, self understanding, support in moving toward positive Women more than men mental health People with Medical insurance • Behavioral-actions learned through basic learning People with higher levels of education principles can lead to serious maladaptive behavior However, many people still do not seek help • Cognitive-habitual ways of thinking affect our moods because of the stigma attached to treatment and our interactions with others Psychoanalysis Freud’s psychodynamic approach has had a strong influence in our understanding of psychotherapy. Freud began career treating patients with Hysteria • Demonstrated that physical symptoms had Psychogenic causes. The Case of Anna O. • Patient fixated psychic energy as a result of unconscious conflicts • Anna’s understanding of her problems led to cure. Psychoanalysis- Sigmund Freud Psychoanalysis Source of Problem: • Unresolved conflicts from early childhood (first five years) • Primary talk therapy • The conflicts are unconscious and unknown to the patient • Takes a long time and is expensive. • Patient develops symptoms which indicate the conflict exists • The therapist is in control and decides whether Basis for recovery: patient improving. • Insight into the unconscious source of current feelings and • “Good” patients tend to be
    [Show full text]
  • Summary of Product Characteristics, Labelling and Package Leaflet
    SUMMARY OF PRODUCT CHARACTERISTICS, LABELLING AND PACKAGE LEAFLET 1 SUMMARY OF PRODUCT CHARACTERISTICS 2 1. NAME OF THE MEDICINAL PRODUCT Acamprosate 333 mg Gastro-resistant Tablets. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each gastro-resistant tablet contains acamprosate calcium 333.0 mg as the active ingredient. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Gastro-resistant tablet. White, round, biconvex coated tablet with “M” over “AC” printed in black ink on one side of the tablet and blank on the other side. 4. CLINICAL PARTICULARS 4.1 Therapeutic indications Acamprosate is indicated as therapy to maintain abstinence in alcohol-dependent patients. It should be combined with counselling. 4.2 Posology and method of administration Posology Adults within the age range 18-65 years - 2 tablets three times daily with meals (2 tablets in the morning, noon and night) in subjects weighing 60kg or more. - In subjects weighing less than 60kg, 4 tablets divided into three daily doses with meals (2 tablets in the morning, 1 at noon and 1 at night). Paediatric population and older people Acamprosate should not be administered to children, adolescents and the elderly. Duration of treatment The recommended treatment period is one year. Treatment with acamprosate should be initiated as soon as possible after the withdrawal period and should be maintained if the patient relapses. Acamprosate does not prevent the harmful effects of continuous alcohol abuse. Continued alcohol abuse negates the therapeutic benefit; therefore acamprosate treatment should only be initiated after weaning therapy, once the patient is abstinent from alcohol. Method of administration For oral use.
    [Show full text]
  • Research and Treatment Sexual Abuse
    Sexual Abuse: A Journal of Research and Treatment http://sax.sagepub.com A Brief History of Behavioral and Cognitive Behavioral Approaches to Sexual Offenders: Part 1. Early Developments D.R. Laws and W.L. Marshall Sex Abuse 2003; 15; 75 DOI: 10.1177/107906320301500201 The online version of this article can be found at: http://sax.sagepub.com/cgi/content/abstract/15/2/75 Published by: http://www.sagepublications.com On behalf of: Association for the Treatment of Sexual Abusers Additional services and information for Sexual Abuse: A Journal of Research and Treatment can be found at: Email Alerts: http://sax.sagepub.com/cgi/alerts Subscriptions: http://sax.sagepub.com/subscriptions Reprints: http://www.sagepub.com/journalsReprints.nav Permissions: http://www.sagepub.com/journalsPermissions.nav Citations (this article cites 71 articles hosted on the SAGE Journals Online and HighWire Press platforms): http://sax.sagepub.com/cgi/content/refs/15/2/75 Downloaded from http://sax.sagepub.com at ATSA on June 17, 2008 © 2003 Association for the Treatment of Sexual Abusers. All rights reserved. Not for commercial use or unauthorized distribution. A Brief History of Behavioral and Cognitive Behavioral Approaches to Sexual Offenders: Part 1. Early Developments D. R. Laws1,3 and W. L. Marshall2 This is the first of two papers which briefly outline the development of behavioral and cognitive behavioral treatment of sexual offenders from the mid-1800s to 1969. We first consider the historic role of Sigmund Freud and note that a broad scientific interest in deviant sexual behavior was well established by 1900. In the early to mid- 20th century, two psychologies were prominent in the development of behavioral approaches, those of John B.
    [Show full text]
  • Impact of Counselling on Employee Retention at the Exit Interviews
    IOSR Journal of Business and Management (IOSR-JBM) e-ISSN: 2278-487X, p-ISSN: 2319-7668. Volume 18, Issue 11. Ver. III (November. 2016), PP 28-36 www.iosrjournals.org Impact of Counselling on Employee Retention at the Exit Interviews M.K.Dinithi Padmasiri Lecturer1, Dr. Lakmini V.K. Jayatilake Senior Lecturer2 1Department of Human Resource Management Faculty of Commerce and Management Studies University of Kelaniya, Sri Lanka 2Department of Commerce and Financial Management Faculty of Commerce and Management Studies University of Kelaniya, Sri Lanka Abstract: The study examines the impact of counselling during the exit interview on employee retention. In a leading apparel company’s labour turnover among machine operators falls between 10% - 12%, which showed that employee turnover is one of the major problems. The general objective of the study was to identify the impact of counselling during the exit interviews on employee retention. Specific objectives were to construct a conceptual framework to study the impact of exit to the organization, to identify the exit interview process of the organization and to provide recommendations to reduce turnover in Machine Operator (MO) level. This study is mainly qualitative in nature. Sample size was 20 machine operators who have decided to resign between April to May in the 2016. Convenience sampling was used and in depth semi-structured interviews were conducted. After the interviews, four machine operators left the establishment. Therapies used during the exit interviews and for employees who retained after the counselling sessions were, behavioral therapy, cognitive behavioral therapy, existential-humanistic therapy, existential-humanistic therapy with behavioral therapy, psychoanalysis therapy with behavioral therapy, and psychoanalysis therapy with cognitive behavioral therapy.
    [Show full text]
  • The Effectiveness and Costs of Alcoholism Treatment
    The Effectiveness and Costs of Alcoholism Treatment March 1983 NTIS order #PB83-192492 ● HEALTH TECHNOLOGY CASE STUDY 22 ● The Effectiveness and Costs of Alcoholism Treatment MARCH 1983 This case study was performed as a part of OTA’S Assessment of Medical Technology and Costs of the Medicare Program Prepared under contract to OTA by: Leonard Saxe, Ph. D., Boston University with: Denise Dougherty, Boston University Katharine Esty, Boston University Michelle Fine, Ph. D., University of Pennsylvania OTA Case Studies are documents containing information on a specific medical technology or area of application that supplements formal OTA assessments. The material is not normally of as immediate policy interest as that in an OTA Report, nor does it present options for Congress to consider. — — Library of Congress Catalog Card Number 83-600708 For sale by the Superintendent of Documents, U.S. Government Printing Office, Washington, D.C. 20402 Preface The Effectiveness and Costs of Alcoholism of the analytical method in carrying out an assess- Treatments is Case Study #22 in OTA’S Health ment. Selection criteria were developed to ensure Technology Case Study Series. It was prepared that case studies provide examples: in response to a request by the Senate Finance ● of types of technologies by function (preven- Committee, Subcommittee on Health, and is part tive, diagnostic, therapeutic, and rehabilita- of OTA’S project on Medical Technology and tive); Costs of the Medicare Program, requested by the ● of types of technologies by physical nature House Committee on Energy and Commerce and (drugs, devices, and procedures); its Subcommittee on Health and the Environment.
    [Show full text]